Early Access — free while we kick the tires
EdgarHawk

CMMB Chemomab Therapeutics Ltd. Insider Trading

Latest: CEO Bought $20K of Shares · May 2026
1 filing analyzed · Latest 2026-06-01
Insider buys
1
Insider sells
0
Unique insiders
1
Direction
Net buying
June 2026
2026-06-01
high
George Adi Mor Buy
Chief Executive Officer
9,804 shares
$20,246
@ $2.07
Significance 6/10

CMMB CEO George Adi Mor buys 9,804 shares for $20,245.98 across 2 purchases; holdings jump 109.6% to 18.8K shares

CEO George Adi Mor executed 2 separate purchases totaling 9,804 shares for $20,245.98 on May 29, 2026, at prices of $2.05 and $2.08 (blended average $2.07), more than doubling his position from 8.9K to 18.8K shares (+109.6%). This concentrated accumulation by the chief executive occurs against a backdrop of significant headwinds: the company is unprofitable (net income of $-8.8M) and the stock has declined 65.3% from its 52-week high of $5.77 to the current $2.00, though it has recovered 37.0% over the past 30 days. The magnitude of the increase in CEO holdings—doubling his pre-transaction stake in a single day—merits investor attention given the company's financial distress, though the recovery in recent price action may reflect other catalysts or broader market conditions.

Get alerts for CMMB

Add CMMB to your watchlist and we'll email you when an insider files a Form 4 — with our AI's significance score and a plain-English read of what it means.

Sign up — free during early access